Skip to main content
Clinical Trials/NCT05334641
NCT05334641
Completed
Not Applicable

The Effect of Music on Pain and Anxiety in Patients Receiving Chemotherapy During COVID-19

Inonu University1 site in 1 country92 target enrollmentMarch 3, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cancer
Sponsor
Inonu University
Enrollment
92
Locations
1
Primary Endpoint
Google Forms (using State and Transient Anxiety Inventory and Visual Analog Skala)
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

Introduction: This study has been conducted to determine the effect of music on pain and anxiety levels in patients receiving chemotherapy during COVID-19.

Methods: The research has been carried out in a real trial model with adult patients receiving chemotherapy. The sample of the study is consisted of 92 patients (45 in the experimental group and 47 for the control group). The data have been collected by the researcher with Google Forms (using State and Transient Anxiety Inventory and Visual Analog Skala) between March 2020 and July 2020, through the links sent to the phones of participants on the day they received chemotherapy.

Results: The mean scores obtained from the post-test STAI (53.11±4.77) and VAS (3.44±2.53) scales in the experimental group have been determined to statistically significantly decrease when compared to the pre-test measurement data (STAI:54.26±4.26; VAS:4.22±2.41) (p<0.05). No statistically significant difference has been determined between pre-test and post-test mean scores of the patients in the control group.

Conclusion: It has been observed that music applications reduce the pain and anxiety levels of patients receiving chemotherapy during the COVID-19 process. It can be recommended to use music applications in the management of pain and anxiety symptoms.

Registry
clinicaltrials.gov
Start Date
March 3, 2020
End Date
June 30, 2020
Last Updated
4 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Gulsum Yetis Koca

Lecturer

Inonu University

Eligibility Criteria

Inclusion Criteria

  • Over the age 18,
  • Being able to communicate,
  • Being literate,
  • Having no diagnosis of psychiatric,
  • Have the necessary technological equipment (phone, internet, etc.)

Exclusion Criteria

  • Existing infection
  • Receiving palliative chemotherapy

Outcomes

Primary Outcomes

Google Forms (using State and Transient Anxiety Inventory and Visual Analog Skala)

Time Frame: The posttest was administered 1 hour after the pretest.

The data have been collected by the researcher with Google Forms (using State and Transient Anxiety Inventory and Visual Analog Skala).The posttest was administered 1 hour after the pretest.

Study Sites (1)

Loading locations...

Similar Trials